JNCASR researchers develop imaging platform for early detection of cancer and neurological disorders
Researchers at JNCASR have developed a new imaging platform called CLEAR that allows for the visualization of multiple proteins in a single biological sample. This technology is expected to significantly improve the diagnosis of cancer and neurological disorders.
Why it matters
The platform offers a faster, high-resolution method for proteomic mapping, which is critical for early disease detection and therapeutic development.
Researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have developed an imaging platform which can transform protein imaging and facilitate detection of cancer and neurobiological diseases.
The article is a technical report on scientific advancement with no political or social bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in